Literature DB >> 31648596

Psychedelic Microdosing: A Subreddit Analysis.

Toby Lea1,2, Nicole Amada3, Henrik Jungaberle4.   

Abstract

Self-administration of very low doses of psychedelic drugs to improve mental health and wellbeing and enhance cognitive function, known as microdosing, has received recent media attention, but little research has been conducted. We conducted a content analysis of discussions about microdosing from the online forum Reddit. We examined motivations, dosing practices, and perceived benefits and limitations of microdosing. Motivations included self-management of mental health issues, improvement of psychosocial wellbeing, and cognitive enhancement. Self-reported benefits included cognitive and creative enhancement, reduced depression and anxiety, enhanced self-insight and mindfulness, improved mood and attitude toward life, improved habits and health behaviors, and improved social interactions and interpersonal connections. Perceived limitations included issues related to dosing, adverse physical effects, taking illegal substances, limited or no mental health or cognitive improvement, increased anxiety, unpleasant "off" days, only short-term benefits, and concerns about dependence and drug-related risks. Standard doses of psychedelic drugs provided in therapeutic settings have potential as novel treatments for some mental health conditions, but clinical research is needed to understand if this is also the case for microdosing. In the meantime, harm reduction resources should be developed and made available to provide the best available information on the safer use of self-administered psychedelics.

Entities:  

Keywords:  LSD; Microdosing; cognitive performance; mental health; psilocybin; treatment

Mesh:

Substances:

Year:  2019        PMID: 31648596     DOI: 10.1080/02791072.2019.1683260

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  7 in total

1.  Natural language signatures of psilocybin microdosing.

Authors:  Camila Sanz; Federico Cavanna; Stephanie Muller; Laura de la Fuente; Federico Zamberlan; Matías Palmucci; Lucie Janeckova; Martin Kuchar; Facundo Carrillo; Adolfo M García; Carla Pallavicini; Enzo Tagliazucchi
Journal:  Psychopharmacology (Berl)       Date:  2022-06-09       Impact factor: 4.415

2.  Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.

Authors:  David Wyndham Lawrence; Robin Carhart-Harris; Roland Griffiths; Christopher Timmermann
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

3.  Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

Authors:  Joseph M Rootman; Maggie Kiraga; Pamela Kryskow; Kalin Harvey; Paul Stamets; Eesmyal Santos-Brault; Kim P C Kuypers; Zach Walsh
Journal:  Sci Rep       Date:  2022-06-30       Impact factor: 4.996

4.  MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Authors:  Robin J Murphy; Rachael L Sumner; William Evans; David Menkes; Ingo Lambrecht; Rhys Ponton; Frederick Sundram; Nicholas Hoeh; Sanya Ram; Lisa Reynolds; Suresh Muthukumaraswamy
Journal:  Trials       Date:  2021-04-23       Impact factor: 2.279

5.  Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

Authors:  Joseph M Rootman; Pamela Kryskow; Kalin Harvey; Paul Stamets; Eesmyal Santos-Brault; Kim P C Kuypers; Vince Polito; Francoise Bourzat; Zach Walsh
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

6.  Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience.

Authors:  Joseph M Peill; Katie E Trinci; Hannes Kettner; Lea J Mertens; Leor Roseman; Christopher Timmermann; Fernando E Rosas; Taylor Lyons; Robin L Carhart-Harris
Journal:  J Psychopharmacol       Date:  2022-01-05       Impact factor: 4.153

7.  How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.

Authors:  Manon van den Berg; Igor Magaraggia; Rudy Schreiber; Todd M Hillhouse; Joseph H Porter
Journal:  Psychopharmacology (Berl)       Date:  2022-03-29       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.